Related Experiment Videos
Complement activation in chronic liver disease
Insights
Chronic active liver disease (CALD) and primary biliary cirrhosis (PBC) show complement activation, unlike alcohol-induced liver disease (ALD). Diminished liver function, not complement activation, affects ALD patients.
Area of Science:
- Immunology
- Hepatology
- Complement System
Background:
- Chronic active liver disease (CALD), primary biliary cirrhosis (PBC), and alcohol-induced liver disease (ALD) are distinct liver conditions.
- The complement system plays a role in immune responses and inflammation.
- Previous research suggests complement activation may be involved in certain liver diseases.
Purpose of the Study:
- To investigate complement system activation in different types of chronic liver disease.
- To differentiate between complement-mediated liver damage and damage due to impaired liver function.
Main Methods:
- Serum concentrations of complement components (e.g., C3d) and regulatory proteins were measured.
- Patients were categorized into groups: HBsAg positive CALD, PBC, HBsAg negative CALD, and ALD.
- Analysis focused on identifying patterns of complement activation and correlation with liver synthetic function.
Main Results:
- HBsAg positive CALD and PBC patients showed increased C3d concentrations, indicating classical and alternative complement pathway activation.
- Regulatory protein levels (C3bINA, beta IH globulin) were normal in these patients.
- HBsAg negative CALD and ALD patients did not show evidence of increased complement activation; reduced complement levels correlated with diminished hepatic synthetic function.
- Specifically, C4 synthesis may be reduced in autoimmune CALD.
Conclusions:
- Complement activation is implicated in HBsAg positive CALD and PBC.
- In HBsAg negative CALD and ALD, reduced complement levels are likely due to impaired liver synthesis rather than activation.
- Autoimmune CALD may involve specific reductions in C4 synthesis.
Abstract:
Patients with HBsAg positive chronic active liver disease (CALD) and primary biliary cirrhosis (PBC) exhibit increased C3d concentrations and changes in the serum concentrations of the complement components consistent with activation of the classical and alternative pathways. In these patients the concentrations of the regulatory proteins, C3b inactivator (C3bINA) and beta IH globulin, are normal. Patients with HBsAg negative CALD and alcohol induced liver disease (ALD) exhibit no evidence of an increased level of complement system activation. In these patients diminished serum concentrations of complement components appear to be related to diminished hepatic synthetic function. C4 synthesis may be specifically reduced in autoimmune chronic active liver disease.